Literature DB >> 11259234

Procalcitonin in children admitted to hospital with community acquired pneumonia.

F Moulin1, J Raymond, M Lorrot, E Marc, J Coste, J L Iniguez, G Kalifa, C Bohuon, D Gendrel.   

Abstract

AIMS: To assess the sensitivity, specificity, and predictive value of procalcitonin (PCT) in differentiating bacterial and viral causes of pneumonia.
METHODS: A total of 72 children with community acquired pneumonia were studied. Ten had positive blood culture for Streptococcus pneumoniae and 15 had bacterial pneumonia according to sputum analysis (S pneumoniae in 15, Haemophilus influenzae b in one). Ten patients had Mycoplasma pneumoniae infection and 37 were infected with viruses, eight of whom had viral infection plus bacterial coinfection. PCT concentration was compared to C reactive protein (CRP) concentration and leucocyte count, and, if samples were available, interleukin 6 (IL-6) concentration.
RESULTS: PCT concentration was greater than 2 microg/l in all 10 patients with blood culture positive for S pneumoniae; in eight of these, CRP concentration was above 60 mg/l. PCT concentration was greater than 1 microg/l in 86% of patients with bacterial infection (including Mycoplasma and bacterial superinfection of viral pneumonia). A CRP concentration of 20 mg/l had a similar sensitivity but a much lower specificity than PCT (40% v 86%) for discriminating between bacterial and viral causes of pneumonia. PCT concentration was significantly higher in cases of bacterial pneumonia with positive blood culture whereas CRP concentration was not. Specificity and sensitivity were lower for leucocyte count and IL-6 concentration.
CONCLUSIONS: PCT concentration, with a threshold of 1 microg/l is more sensitive and specific and has greater positive and negative predictive values than CRP, IL-6, or white blood cell count for differentiating bacterial and viral causes of community pneumonia in untreated children admitted to hospital as emergency cases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259234      PMCID: PMC1718706          DOI: 10.1136/adc.84.4.332

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  20 in total

1.  Pneumonia in childhood: etiology and response to antimicrobial therapy.

Authors:  O Ruuskanen; H Nohynek; T Ziegler; R Capeding; H Rikalainen; P Huovinen; M Leinonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

2.  Measurement of procalcitonin levels in children with bacterial or viral meningitis.

Authors:  D Gendrel; J Raymond; M Assicot; F Moulin; J L Iniguez; P Lebon; C Bohuon
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

3.  Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin.

Authors:  F M Brunkhorst; O K Eberhard; R Brunkhorst
Journal:  Crit Care Med       Date:  1999-10       Impact factor: 7.598

4.  Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections.

Authors:  D Gendrel; J Raymond; J Coste; F Moulin; M Lorrot; S Guérin; S Ravilly; H Lefèvre; C Royer; C Lacombe; P Palmer; C Bohuon
Journal:  Pediatr Infect Dis J       Date:  1999-10       Impact factor: 2.129

5.  Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock.

Authors:  M Hatherill; S M Tibby; C Turner; N Ratnavel; I A Murdoch
Journal:  Crit Care Med       Date:  2000-07       Impact factor: 7.598

6.  Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children.

Authors:  P Toikka; K Irjala; T Juvén; R Virkki; J Mertsola; M Leinonen; O Ruuskanen
Journal:  Pediatr Infect Dis J       Date:  2000-07       Impact factor: 2.129

7.  C-reactive protein in early detection of bacteremic versus viral infections in immunocompetent and compromised children.

Authors:  H Peltola; M Jaakkola
Journal:  J Pediatr       Date:  1988-10       Impact factor: 4.406

8.  High serum procalcitonin concentrations in patients with sepsis and infection.

Authors:  M Assicot; D Gendrel; H Carsin; J Raymond; J Guilbaud; C Bohuon
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

9.  Advances in statistical methodology for the evaluation of diagnostic and laboratory tests.

Authors:  G Campbell
Journal:  Stat Med       Date:  1994 Mar 15-Apr 15       Impact factor: 2.373

10.  Bacterial antibody assays in the diagnosis of acute lower respiratory tract infection in children.

Authors:  H Nohynek; J Eskola; M Kleemola; E Jalonen; P Saikku; M Leinonen
Journal:  Pediatr Infect Dis J       Date:  1995-06       Impact factor: 2.129

View more
  52 in total

1.  Serum procalcitonin is not an early marker of pulmonary exacerbation in children with cystic fibrosis.

Authors:  Jacoba Johanna Louw; Jaan Toelen; Marijke Proesmans; François Vermeulen; Jaak Billen; Kris de Boeck
Journal:  Eur J Pediatr       Date:  2011-06-01       Impact factor: 3.183

2.  Legionella pneumonia and serum procalcitonin.

Authors:  Laura Franzin; Daniela Cabodi
Journal:  Curr Microbiol       Date:  2004-10-28       Impact factor: 2.188

3.  Pre-emptive antibiotic treatment vs 'standard' treatment in patients with elevated serum procalcitonin levels after elective colorectal surgery: a prospective randomised pilot study.

Authors:  Ansgar Michael Chromik; Frank Endter; Waldemar Uhl; Arnulf Thiede; Hans Bernd Reith; Ulrich Mittelkötter
Journal:  Langenbecks Arch Surg       Date:  2005-12-21       Impact factor: 3.445

4.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

5.  Cerebrospinal fluid procalcitonin as a biomarker of bacterial meningitis in neonates.

Authors:  Z Reshi; M Nazir; W Wani; M Malik; J Iqbal; S Wajid
Journal:  J Perinatol       Date:  2017-05-25       Impact factor: 2.521

6.  Is procalcitonin better than C-reactive protein for early diagnosis of bacterial pneumonia in children?

Authors:  Dilshad Ahmad Khan; Aisha Rahman; Farooq Ahmad Khan
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

7.  Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ.

Authors:  Stefan Krüger; Santiago Ewig; Jana Papassotiriou; Jan Kunde; Reinhard Marre; Heike von Baum; Norbert Suttor; Tobias Welte
Journal:  Respir Res       Date:  2009-07-12

Review 8.  A systematic review on the diagnosis of pediatric bacterial pneumonia: when gold is bronze.

Authors:  Tim Lynch; Liza Bialy; James D Kellner; Martin H Osmond; Terry P Klassen; Tamara Durec; Robin Leicht; David W Johnson
Journal:  PLoS One       Date:  2010-08-06       Impact factor: 3.240

9.  Serum and pleural fluid procalcitonin in predicting bacterial infection in patients with parapneumonic effusion.

Authors:  Yang-Ching Ko; Wen-Pin Wu; Chi-Sen Hsu; Mong-Ping Dai; Chien-Chih Ou; Chih-Hsiung Kao
Journal:  J Korean Med Sci       Date:  2009-06-12       Impact factor: 2.153

10.  Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia.

Authors:  Young Ae Kang; Sung-Youn Kwon; Ho Il Yoon; Jae Ho Lee; Choon-Taek Lee
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.